Screener
USANA Health Sciences USNA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Income taxes | 8,506 | 7,449 |
| Net earnings | 6,959 | 9,290 |
| Net (loss) earnings attributable to redeemable noncontrolling interest | (556) | (112) |
| Net earnings attributable to USANA | $7,515 | $9,402 |
| Earnings per common share attributable to USANA | ||
| Basic | $0.41 | $0.49 |
| Diluted | $0.41 | $0.49 |
| Weighted average common shares outstanding |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's net income?
- USANA Health Sciences (USNA) reported net income of $7.52M in Q1 2026.
- How has USANA Health Sciences's net income changed year-over-year?
- USANA Health Sciences's net income decreased by 20.1% year-over-year, from $9.4M to $7.52M.
- What is the long-term trend for USANA Health Sciences's net income?
- Over 3 years (2021 to 2024), USANA Health Sciences's net income has grown at a -28.8% compound annual growth rate (CAGR), from $116.51M to $42.03M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about USANA Health Sciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude